APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Biothrax (Anthrax Vaccine)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Biothrax (Anthrax Vaccine) Market Outlook and Growth Opportunities 2026

Report ID 17397102042 January 2026219 pages

Choose your research edition.

Industry ResearchBiothrax (Anthrax Vaccine) Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Biothrax (Anthrax Vaccine) Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Biothrax (Anthrax Vaccine) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biothrax (Anthrax Vaccine) Market Outlook and Growth Opportunities 2026219 pages · $4,250 USDMarket Analysis & ForecastGlobal Biothrax (Anthrax Vaccine) Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Biothrax (Anthrax Vaccine) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Biothrax (Anthrax Vaccine) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biothrax (Anthrax Vaccine) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biothrax (Anthrax Vaccine) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Biothrax (Anthrax Vaccine) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Biothrax (Anthrax Vaccine) market include Merck, Tiankang, Zoetis, Vecol, Rosenbusch, Prondil, PharmAthene, Merial and JOVAC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Biothrax (Anthrax Vaccine) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biothrax (Anthrax Vaccine) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biothrax (Anthrax Vaccine) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Biothrax (Anthrax Vaccine) market size, projected growth trends, production technologies, key applications, and end-use industries.

Biothrax (Anthrax Vaccine) Segment by Company

Merck

Tiankang

Zoetis

Vecol

Rosenbusch

Prondil

PharmAthene

Merial

JOVAC

IVPM

Intervac

Indian Immunologicals

CVCRI

Colorado Serum

Ceva Santé Animale

CDV

CAVAC

Botswana Vaccine Institute

Biogénesis-Bago

Bayer Sanidad Animal

Agrovet

Biothrax (Anthrax Vaccine) Segment by Type

Live Vaccines

Cell Free PA Vaccines

Biothrax (Anthrax Vaccine) Segment by Application

Human Use

Animal Use

Biothrax (Anthrax Vaccine) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Biothrax (Anthrax Vaccine) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Biothrax (Anthrax Vaccine) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Biothrax (Anthrax Vaccine) significant trends, drivers, influence factors in global and regions.

6. To analyze Biothrax (Anthrax Vaccine) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biothrax (Anthrax Vaccine) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biothrax (Anthrax Vaccine) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biothrax (Anthrax Vaccine).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Biothrax (Anthrax Vaccine) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biothrax (Anthrax Vaccine) industry.

Chapter 3: Detailed analysis of Biothrax (Anthrax Vaccine) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Biothrax (Anthrax Vaccine) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Biothrax (Anthrax Vaccine) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Biothrax (Anthrax Vaccine) Industry Trends Table 2. Biothrax (Anthrax Vaccine) Industry Drivers Table 3. Biothrax (Anthrax Vaccine) Industry Opportunities and Challenges Table 4. Biothrax (Anthrax Vaccine) Industry Restraints Table 5. Global Biothrax (Anthrax Vaccine) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Biothrax (Anthrax Vaccine) Revenue Share by Company (2021-2026) Table 7. Global Biothrax (Anthrax Vaccine) Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Biothrax (Anthrax Vaccine) Sales Volume Share by Company (2021-2026) Table 9. Global Biothrax (Anthrax Vaccine) Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Biothrax (Anthrax Vaccine) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Biothrax (Anthrax Vaccine) Key Company Manufacturing Base & Headquarters Table 12. Global Biothrax (Anthrax Vaccine) Company, Product Type & Application Table 13. Global Biothrax (Anthrax Vaccine) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Biothrax (Anthrax Vaccine) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Live Vaccines Table 18. Significant Companies of Cell Free PA Vaccines Table 19. Global Biothrax (Anthrax Vaccine) Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Biothrax (Anthrax Vaccine) Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Biothrax (Anthrax Vaccine) Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Biothrax (Anthrax Vaccine) Sales Volume Share by Type (2021-2026) Table 23. Global Biothrax (Anthrax Vaccine) Sales Volume Share by Type (2027-2032) Table 24. Global Biothrax (Anthrax Vaccine) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Biothrax (Anthrax Vaccine) Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Biothrax (Anthrax Vaccine) Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Biothrax (Anthrax Vaccine) Sales Value Share by Type (2021-2026) Table 28. Global Biothrax (Anthrax Vaccine) Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Human Use Table 30. Significant Companies of Animal Use Table 31. Global Biothrax (Anthrax Vaccine) Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Biothrax (Anthrax Vaccine) Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Biothrax (Anthrax Vaccine) Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Biothrax (Anthrax Vaccine) Sales Volume Share by Application (2021-2026) Table 35. Global Biothrax (Anthrax Vaccine) Sales Volume Share by Application (2027-2032) Table 36. Global Biothrax (Anthrax Vaccine) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Biothrax (Anthrax Vaccine) Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Biothrax (Anthrax Vaccine) Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Biothrax (Anthrax Vaccine) Sales Value Share by Application (2021-2026) Table 40. Global Biothrax (Anthrax Vaccine) Sales Value Share by Application (2027-2032) Table 41. Global Biothrax (Anthrax Vaccine) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Biothrax (Anthrax Vaccine) Sales by Region (2021-2026) & (K Units) Table 43. Global Biothrax (Anthrax Vaccine) Sales Market Share by Region (2021-2026) Table 44. Global Biothrax (Anthrax Vaccine) Sales by Region (2027-2032) & (K Units) Table 45. Global Biothrax (Anthrax Vaccine) Sales Market Share by Region (2027-2032) Table 46. Global Biothrax (Anthrax Vaccine) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Biothrax (Anthrax Vaccine) Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Biothrax (Anthrax Vaccine) Sales Value Share by Region (2021-2026) Table 49. Global Biothrax (Anthrax Vaccine) Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Biothrax (Anthrax Vaccine) Sales Value Share by Region (2027-2032) Table 51. Global Biothrax (Anthrax Vaccine) Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Biothrax (Anthrax Vaccine) Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Biothrax (Anthrax Vaccine) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Biothrax (Anthrax Vaccine) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Biothrax (Anthrax Vaccine) Sales by Country (2021-2026) & (K Units) Table 56. Global Biothrax (Anthrax Vaccine) Sales Market Share by Country (2021-2026) Table 57. Global Biothrax (Anthrax Vaccine) Sales by Country (2027-2032) & (K Units) Table 58. Global Biothrax (Anthrax Vaccine) Sales Market Share by Country (2027-2032) Table 59. Global Biothrax (Anthrax Vaccine) Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Biothrax (Anthrax Vaccine) Sales Value Market Share by Country (2021-2026) Table 61. Global Biothrax (Anthrax Vaccine) Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Biothrax (Anthrax Vaccine) Sales Value Market Share by Country (2027-2032) Table 63. Merck Company Information Table 64. Merck Business Overview Table 65. Merck Biothrax (Anthrax Vaccine) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Merck Biothrax (Anthrax Vaccine) Product Portfolio Table 67. Merck Recent Development Table 68. Tiankang Company Information Table 69. Tiankang Business Overview Table 70. Tiankang Biothrax (Anthrax Vaccine) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Tiankang Biothrax (Anthrax Vaccine) Product Portfolio Table 72. Tiankang Recent Development Table 73. Zoetis Company Information Table 74. Zoetis Business Overview Table 75. Zoetis Biothrax (Anthrax Vaccine) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Zoetis Biothrax (Anthrax Vaccine) Product Portfolio Table 77. Zoetis Recent Development Table 78. Vecol Company Information Table 79. Vecol Business Overview Table 80. Vecol Biothrax (Anthrax Vaccine) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Vecol Biothrax (Anthrax Vaccine) Product Portfolio Table 82. Vecol Recent Development Table 83. Rosenbusch Company Information Table 84. Rosenbusch Business Overview Table 85. Rosenbusch Biothrax (Anthrax Vaccine) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Rosenbusch Biothrax (Anthrax Vaccine) Product Portfolio Table 87. Rosenbusch Recent Development Table 88. Prondil Company Information Table 89. Prondil Business Overview Table 90. Prondil Biothrax (Anthrax Vaccine) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Prondil Biothrax (Anthrax Vaccine) Product Portfolio Table 92. Prondil Recent Development Table 93. PharmAthene Company Information Table 94. PharmAthene Business Overview Table 95. PharmAthene Biothrax (Anthrax Vaccine) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. PharmAthene Biothrax (Anthrax Vaccine) Product Portfolio Table 97. PharmAthene Recent Development Table 98. Merial Company Information Table 99. Merial Business Overview Table 100. Merial Biothrax (Anthrax Vaccine) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Merial Biothrax (Anthrax Vaccine) Product Portfolio Table 102. Merial Recent Development Table 103. JOVAC Company Information Table 104. JOVAC Business Overview Table 105. JOVAC Biothrax (Anthrax Vaccine) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. JOVAC Biothrax (Anthrax Vaccine) Product Portfolio Table 107. JOVAC Recent Development Table 108. IVPM Company Information Table 109. IVPM Business Overview Table 110. IVPM Biothrax (Anthrax Vaccine) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. IVPM Biothrax (Anthrax Vaccine) Product Portfolio Table 112. IVPM Recent Development Table 113. Intervac Company Information Table 114. Intervac Business Overview Table 115. Intervac Biothrax (Anthrax Vaccine) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Intervac Biothrax (Anthrax Vaccine) Product Portfolio Table 117. Intervac Recent Development Table 118. Indian Immunologicals Company Information Table 119. Indian Immunologicals Business Overview Table 120. Indian Immunologicals Biothrax (Anthrax Vaccine) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Indian Immunologicals Biothrax (Anthrax Vaccine) Product Portfolio Table 122. Indian Immunologicals Recent Development Table 123. CVCRI Company Information Table 124. CVCRI Business Overview Table 125. CVCRI Biothrax (Anthrax Vaccine) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. CVCRI Biothrax (Anthrax Vaccine) Product Portfolio Table 127. CVCRI Recent Development Table 128. Colorado Serum Company Information Table 129. Colorado Serum Business Overview Table 130. Colorado Serum Biothrax (Anthrax Vaccine) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Colorado Serum Biothrax (Anthrax Vaccine) Product Portfolio Table 132. Colorado Serum Recent Development Table 133. Ceva Santé Animale Company Information Table 134. Ceva Santé Animale Business Overview Table 135. Ceva Santé Animale Biothrax (Anthrax Vaccine) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Ceva Santé Animale Biothrax (Anthrax Vaccine) Product Portfolio Table 137. Ceva Santé Animale Recent Development Table 138. CDV Company Information Table 139. CDV Business Overview Table 140. CDV Biothrax (Anthrax Vaccine) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. CDV Biothrax (Anthrax Vaccine) Product Portfolio Table 142. CDV Recent Development Table 143. CAVAC Company Information Table 144. CAVAC Business Overview Table 145. CAVAC Biothrax (Anthrax Vaccine) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. CAVAC Biothrax (Anthrax Vaccine) Product Portfolio Table 147. CAVAC Recent Development Table 148. Botswana Vaccine Institute Company Information Table 149. Botswana Vaccine Institute Business Overview Table 150. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 151. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Product Portfolio Table 152. Botswana Vaccine Institute Recent Development Table 153. Biogénesis-Bago Company Information Table 154. Biogénesis-Bago Business Overview Table 155. Biogénesis-Bago Biothrax (Anthrax Vaccine) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 156. Biogénesis-Bago Biothrax (Anthrax Vaccine) Product Portfolio Table 157. Biogénesis-Bago Recent Development Table 158. Bayer Sanidad Animal Company Information Table 159. Bayer Sanidad Animal Business Overview Table 160. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 161. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Product Portfolio Table 162. Bayer Sanidad Animal Recent Development Table 163. Agrovet Company Information Table 164. Agrovet Business Overview Table 165. Agrovet Biothrax (Anthrax Vaccine) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 166. Agrovet Biothrax (Anthrax Vaccine) Product Portfolio Table 167. Agrovet Recent Development Table 168. Key Raw Materials Table 169. Raw Materials Key Suppliers Table 170. Biothrax (Anthrax Vaccine) Distributors List Table 171. Biothrax (Anthrax Vaccine) Customers List Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Biothrax (Anthrax Vaccine) Product Image Figure 2. Global Biothrax (Anthrax Vaccine) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biothrax (Anthrax Vaccine) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Biothrax (Anthrax Vaccine) Sales (2021-2032) & (K Units) Figure 5. Global Biothrax (Anthrax Vaccine) Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Biothrax (Anthrax Vaccine) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Live Vaccines Image Figure 10. Cell Free PA Vaccines Image Figure 11. Global Biothrax (Anthrax Vaccine) Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Biothrax (Anthrax Vaccine) Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Biothrax (Anthrax Vaccine) Sales Volume Share by Type (2021-2032) Figure 14. Global Biothrax (Anthrax Vaccine) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Biothrax (Anthrax Vaccine) Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Biothrax (Anthrax Vaccine) Sales Value Share by Type (2021-2032) Figure 17. Human Use Image Figure 18. Animal Use Image Figure 19. Global Biothrax (Anthrax Vaccine) Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Biothrax (Anthrax Vaccine) Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Biothrax (Anthrax Vaccine) Sales Volume Share by Application (2021-2032) Figure 22. Global Biothrax (Anthrax Vaccine) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Biothrax (Anthrax Vaccine) Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Biothrax (Anthrax Vaccine) Sales Value Share by Application (2021-2032) Figure 25. Global Biothrax (Anthrax Vaccine) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Biothrax (Anthrax Vaccine) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Biothrax (Anthrax Vaccine) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Biothrax (Anthrax Vaccine) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Biothrax (Anthrax Vaccine) Sales Value (2021-2032) & (US$ Million) Figure 30. North America Biothrax (Anthrax Vaccine) Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Biothrax (Anthrax Vaccine) Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Biothrax (Anthrax Vaccine) Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Biothrax (Anthrax Vaccine) Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Biothrax (Anthrax Vaccine) Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Biothrax (Anthrax Vaccine) Sales Value (2021-2032) & (US$ Million) Figure 36. South America Biothrax (Anthrax Vaccine) Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Biothrax (Anthrax Vaccine) Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Biothrax (Anthrax Vaccine) Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Biothrax (Anthrax Vaccine) Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Biothrax (Anthrax Vaccine) Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Live Vaccines
  • Cell Free PA Vaccines
Applications
  • Human Use
  • Animal Use
Companies covered
  • Merck
  • Tiankang
  • Zoetis
  • Vecol
  • Rosenbusch
  • Prondil
  • PharmAthene
  • Merial
  • JOVAC
  • IVPM
  • Intervac
  • Indian Immunologicals
  • CVCRI
  • Colorado Serum
  • Ceva Santé Animale
  • CDV
  • CAVAC
  • Botswana Vaccine Institute
  • Biogénesis-Bago
  • Bayer Sanidad Animal
  • Agrovet

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Biothrax (Anthrax Vaccine) Sales Value (2021-2032)
  4. 1.2.2 Global Biothrax (Anthrax Vaccine) Sales Volume (2021-2032)
  5. 1.2.3 Global Biothrax (Anthrax Vaccine) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Biothrax (Anthrax Vaccine) Market Dynamics
  1. 2.1 Biothrax (Anthrax Vaccine) Industry Trends
  2. 2.2 Biothrax (Anthrax Vaccine) Industry Drivers
  3. 2.3 Biothrax (Anthrax Vaccine) Industry Opportunities and Challenges
  4. 2.4 Biothrax (Anthrax Vaccine) Industry Restraints
3 Biothrax (Anthrax Vaccine) Market by Company
  1. 3.1 Global Biothrax (Anthrax Vaccine) Company Revenue Ranking in 2025
  2. 3.2 Global Biothrax (Anthrax Vaccine) Revenue by Company (2021-2026)
  3. 3.3 Global Biothrax (Anthrax Vaccine) Sales Volume by Company (2021-2026)
  4. 3.4 Global Biothrax (Anthrax Vaccine) Average Price by Company (2021-2026)
  5. 3.5 Global Biothrax (Anthrax Vaccine) Company Ranking (2024-2026)
  6. 3.6 Global Biothrax (Anthrax Vaccine) Company Manufacturing Base and Headquarters
  7. 3.7 Global Biothrax (Anthrax Vaccine) Company Product Type and Application
  8. 3.8 Global Biothrax (Anthrax Vaccine) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Biothrax (Anthrax Vaccine) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Biothrax (Anthrax Vaccine) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Biothrax (Anthrax Vaccine) Market by Type
  1. 4.1 Biothrax (Anthrax Vaccine) Type Introduction
  2. 4.1.1 Live Vaccines
  3. 4.1.2 Cell Free PA Vaccines
  4. 4.2 Global Biothrax (Anthrax Vaccine) Sales Volume by Type
  5. 4.2.1 Global Biothrax (Anthrax Vaccine) Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Biothrax (Anthrax Vaccine) Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Biothrax (Anthrax Vaccine) Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Biothrax (Anthrax Vaccine) Sales Value by Type
  9. 4.3.1 Global Biothrax (Anthrax Vaccine) Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Biothrax (Anthrax Vaccine) Sales Value by Type (2021-2032)
  11. 4.3.3 Global Biothrax (Anthrax Vaccine) Sales Value Share by Type (2021-2032)
5 Biothrax (Anthrax Vaccine) Market by Application
  1. 5.1 Biothrax (Anthrax Vaccine) Application Introduction
  2. 5.1.1 Human Use
  3. 5.1.2 Animal Use
  4. 5.2 Global Biothrax (Anthrax Vaccine) Sales Volume by Application
  5. 5.2.1 Global Biothrax (Anthrax Vaccine) Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Biothrax (Anthrax Vaccine) Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Biothrax (Anthrax Vaccine) Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Biothrax (Anthrax Vaccine) Sales Value by Application
  9. 5.3.1 Global Biothrax (Anthrax Vaccine) Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Biothrax (Anthrax Vaccine) Sales Value by Application (2021-2032)
  11. 5.3.3 Global Biothrax (Anthrax Vaccine) Sales Value Share by Application (2021-2032)
6 Biothrax (Anthrax Vaccine) Regional Sales and Value Analysis
  1. 6.1 Global Biothrax (Anthrax Vaccine) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Biothrax (Anthrax Vaccine) Sales by Region (2021-2032)
  3. 6.2.1 Global Biothrax (Anthrax Vaccine) Sales by Region: 2021-2026
  4. 6.2.2 Global Biothrax (Anthrax Vaccine) Sales by Region (2027-2032)
  5. 6.3 Global Biothrax (Anthrax Vaccine) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Biothrax (Anthrax Vaccine) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Biothrax (Anthrax Vaccine) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Biothrax (Anthrax Vaccine) Sales Value by Region (2027-2032)
  9. 6.5 Global Biothrax (Anthrax Vaccine) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Biothrax (Anthrax Vaccine) Sales Value (2021-2032)
  12. 6.6.2 North America Biothrax (Anthrax Vaccine) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Biothrax (Anthrax Vaccine) Sales Value (2021-2032)
  15. 6.7.2 Europe Biothrax (Anthrax Vaccine) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Biothrax (Anthrax Vaccine) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Biothrax (Anthrax Vaccine) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Biothrax (Anthrax Vaccine) Sales Value (2021-2032)
  21. 6.9.2 South America Biothrax (Anthrax Vaccine) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Biothrax (Anthrax Vaccine) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Biothrax (Anthrax Vaccine) Sales Value Share by Country, 2025 VS 2032
7 Biothrax (Anthrax Vaccine) Country-level Sales and Value Analysis
  1. 7.1 Global Biothrax (Anthrax Vaccine) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Biothrax (Anthrax Vaccine) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Biothrax (Anthrax Vaccine) Sales by Country (2021-2032)
  4. 7.3.1 Global Biothrax (Anthrax Vaccine) Sales by Country (2021-2026)
  5. 7.3.2 Global Biothrax (Anthrax Vaccine) Sales by Country (2027-2032)
  6. 7.4 Global Biothrax (Anthrax Vaccine) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Biothrax (Anthrax Vaccine) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Biothrax (Anthrax Vaccine) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Biothrax (Anthrax Vaccine) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Biothrax (Anthrax Vaccine) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Biothrax (Anthrax Vaccine) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck Biothrax (Anthrax Vaccine) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Merck Biothrax (Anthrax Vaccine) Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 Tiankang
  8. 8.2.1 Tiankang Company Information
  9. 8.2.2 Tiankang Business Overview
  10. 8.2.3 Tiankang Biothrax (Anthrax Vaccine) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Tiankang Biothrax (Anthrax Vaccine) Product Portfolio
  12. 8.2.5 Tiankang Recent Developments
  13. 8.3 Zoetis
  14. 8.3.1 Zoetis Company Information
  15. 8.3.2 Zoetis Business Overview
  16. 8.3.3 Zoetis Biothrax (Anthrax Vaccine) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Zoetis Biothrax (Anthrax Vaccine) Product Portfolio
  18. 8.3.5 Zoetis Recent Developments
  19. 8.4 Vecol
  20. 8.4.1 Vecol Company Information
  21. 8.4.2 Vecol Business Overview
  22. 8.4.3 Vecol Biothrax (Anthrax Vaccine) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Vecol Biothrax (Anthrax Vaccine) Product Portfolio
  24. 8.4.5 Vecol Recent Developments
  25. 8.5 Rosenbusch
  26. 8.5.1 Rosenbusch Company Information
  27. 8.5.2 Rosenbusch Business Overview
  28. 8.5.3 Rosenbusch Biothrax (Anthrax Vaccine) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Rosenbusch Biothrax (Anthrax Vaccine) Product Portfolio
  30. 8.5.5 Rosenbusch Recent Developments
  31. 8.6 Prondil
  32. 8.6.1 Prondil Company Information
  33. 8.6.2 Prondil Business Overview
  34. 8.6.3 Prondil Biothrax (Anthrax Vaccine) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Prondil Biothrax (Anthrax Vaccine) Product Portfolio
  36. 8.6.5 Prondil Recent Developments
  37. 8.7 PharmAthene
  38. 8.7.1 PharmAthene Company Information
  39. 8.7.2 PharmAthene Business Overview
  40. 8.7.3 PharmAthene Biothrax (Anthrax Vaccine) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 PharmAthene Biothrax (Anthrax Vaccine) Product Portfolio
  42. 8.7.5 PharmAthene Recent Developments
  43. 8.8 Merial
  44. 8.8.1 Merial Company Information
  45. 8.8.2 Merial Business Overview
  46. 8.8.3 Merial Biothrax (Anthrax Vaccine) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Merial Biothrax (Anthrax Vaccine) Product Portfolio
  48. 8.8.5 Merial Recent Developments
  49. 8.9 JOVAC
  50. 8.9.1 JOVAC Company Information
  51. 8.9.2 JOVAC Business Overview
  52. 8.9.3 JOVAC Biothrax (Anthrax Vaccine) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 JOVAC Biothrax (Anthrax Vaccine) Product Portfolio
  54. 8.9.5 JOVAC Recent Developments
  55. 8.10 IVPM
  56. 8.10.1 IVPM Company Information
  57. 8.10.2 IVPM Business Overview
  58. 8.10.3 IVPM Biothrax (Anthrax Vaccine) Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 IVPM Biothrax (Anthrax Vaccine) Product Portfolio
  60. 8.10.5 IVPM Recent Developments
  61. 8.11 Intervac
  62. 8.11.1 Intervac Company Information
  63. 8.11.2 Intervac Business Overview
  64. 8.11.3 Intervac Biothrax (Anthrax Vaccine) Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Intervac Biothrax (Anthrax Vaccine) Product Portfolio
  66. 8.11.5 Intervac Recent Developments
  67. 8.12 Indian Immunologicals
  68. 8.12.1 Indian Immunologicals Company Information
  69. 8.12.2 Indian Immunologicals Business Overview
  70. 8.12.3 Indian Immunologicals Biothrax (Anthrax Vaccine) Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Indian Immunologicals Biothrax (Anthrax Vaccine) Product Portfolio
  72. 8.12.5 Indian Immunologicals Recent Developments
  73. 8.13 CVCRI
  74. 8.13.1 CVCRI Company Information
  75. 8.13.2 CVCRI Business Overview
  76. 8.13.3 CVCRI Biothrax (Anthrax Vaccine) Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 CVCRI Biothrax (Anthrax Vaccine) Product Portfolio
  78. 8.13.5 CVCRI Recent Developments
  79. 8.14 Colorado Serum
  80. 8.14.1 Colorado Serum Company Information
  81. 8.14.2 Colorado Serum Business Overview
  82. 8.14.3 Colorado Serum Biothrax (Anthrax Vaccine) Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Colorado Serum Biothrax (Anthrax Vaccine) Product Portfolio
  84. 8.14.5 Colorado Serum Recent Developments
  85. 8.15 Ceva Santé Animale
  86. 8.15.1 Ceva Santé Animale Company Information
  87. 8.15.2 Ceva Santé Animale Business Overview
  88. 8.15.3 Ceva Santé Animale Biothrax (Anthrax Vaccine) Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Ceva Santé Animale Biothrax (Anthrax Vaccine) Product Portfolio
  90. 8.15.5 Ceva Santé Animale Recent Developments
  91. 8.16 CDV
  92. 8.16.1 CDV Company Information
  93. 8.16.2 CDV Business Overview
  94. 8.16.3 CDV Biothrax (Anthrax Vaccine) Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 CDV Biothrax (Anthrax Vaccine) Product Portfolio
  96. 8.16.5 CDV Recent Developments
  97. 8.17 CAVAC
  98. 8.17.1 CAVAC Company Information
  99. 8.17.2 CAVAC Business Overview
  100. 8.17.3 CAVAC Biothrax (Anthrax Vaccine) Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 CAVAC Biothrax (Anthrax Vaccine) Product Portfolio
  102. 8.17.5 CAVAC Recent Developments
  103. 8.18 Botswana Vaccine Institute
  104. 8.18.1 Botswana Vaccine Institute Company Information
  105. 8.18.2 Botswana Vaccine Institute Business Overview
  106. 8.18.3 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Product Portfolio
  108. 8.18.5 Botswana Vaccine Institute Recent Developments
  109. 8.19 Biogénesis-Bago
  110. 8.19.1 Biogénesis-Bago Company Information
  111. 8.19.2 Biogénesis-Bago Business Overview
  112. 8.19.3 Biogénesis-Bago Biothrax (Anthrax Vaccine) Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Biogénesis-Bago Biothrax (Anthrax Vaccine) Product Portfolio
  114. 8.19.5 Biogénesis-Bago Recent Developments
  115. 8.20 Bayer Sanidad Animal
  116. 8.20.1 Bayer Sanidad Animal Company Information
  117. 8.20.2 Bayer Sanidad Animal Business Overview
  118. 8.20.3 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Product Portfolio
  120. 8.20.5 Bayer Sanidad Animal Recent Developments
  121. 8.21 Agrovet
  122. 8.21.1 Agrovet Company Information
  123. 8.21.2 Agrovet Business Overview
  124. 8.21.3 Agrovet Biothrax (Anthrax Vaccine) Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Agrovet Biothrax (Anthrax Vaccine) Product Portfolio
  126. 8.21.5 Agrovet Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Biothrax (Anthrax Vaccine) Value Chain Analysis
  2. 9.1.1 Biothrax (Anthrax Vaccine) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Biothrax (Anthrax Vaccine) Sales Mode & Process
  6. 9.2 Biothrax (Anthrax Vaccine) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Biothrax (Anthrax Vaccine) Distributors
  9. 9.2.3 Biothrax (Anthrax Vaccine) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst